Clinical Trials Logo

Childhood Obesity clinical trials

View clinical trials related to Childhood Obesity.

Filter by:

NCT ID: NCT04297059 Completed - Childhood Obesity Clinical Trials

The Ajyal Salima Longitudinal Study to Prevent Childhood Obesity

Start date: September 1, 2014
Phase: N/A
Study type: Interventional

The study was carried out to determine the long-term effectiveness of a school-based intervention programme when implemented over 2 years and its sustained effect one year later.

NCT ID: NCT04284670 Recruiting - Childhood Obesity Clinical Trials

The Effect of Eccentric Training on Anthropometrics, Physical Fitness and Bone Strength in Overweight Children

Start date: February 20, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of aerobic eccentric training in overweight and obese children.

NCT ID: NCT04265794 Recruiting - Childhood Obesity Clinical Trials

A Cluster Randomized Trial of the H2GO! Program

Start date: October 22, 2020
Phase: N/A
Study type: Interventional

This proposal involves a collaboration with the Massachusetts Alliance of Boys and Girls Clubs. The goal is to evaluate the efficacy of youth empowerment intervention targeting sugar-sweetened beverage consumption on childhood obesity among youth. The 12-session 6-week intervention consists of health and narrative sessions and youth-led activities. For this cluster randomized controlled trial [RCT} at 10 sites, the investigators will recruit 45 parent-child pairs per site for a total of 450 parent-child pairs. The primary outcome is child participants' body mass index (BMI) z scores. Secondary outcomes include children's sugar-sweetened beverage intake, water intake, and youth empowerment. Change in outcomes over time among participants in the intervention sites will be compared to change in outcomes over time among participants

NCT ID: NCT04261985 Not yet recruiting - Childhood Obesity Clinical Trials

A Mobile Phone Based Pilot Intervention to Prevent Obesity in Latino Preschool Children

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

To pilot a stand-alone mobile phone intervention with Latino caregivers of 2- to 5-year olds, using a prospective control group design, to assess feasibility and preliminary effect sizes on children's BMI changes (primary outcome) and dietary and physical activity changes (secondary outcomes) at 6 months post-baseline, in preparation for a larger randomized trial to evaluate the intervention's efficacy.

NCT ID: NCT04196556 Recruiting - Childhood Obesity Clinical Trials

Effectiveness of an Intervention Programme for Childhood Obesity: FAMILIACT

FAMILIACT
Start date: December 10, 2022
Phase: N/A
Study type: Interventional

Objectives. To assess the effectiveness of a programmed family/group intervention to reduce weight in the treatment of obesity in children 7 to 12 years old in front of usual treatment. Design. Cluster randomized controlled trial, multicenter. Location. Primary health care centers. Participants. Obese children 7 to 12 years old of primary health care centers. Body mass index (BMI) > P 97. Patients give Informed consent. Sampling. Randomized cluster assigned. Assignation unit: primary care center. Analysis unit. Patient (Children and childminder). Size: 280 patients (140 by group). Principal measurements Variables.BMI z score (BMI-SDS) after the 6 month intervention and after 12 -month follow-up. Secondary Measurements Variables. quality of Mediterranean diet, Brief questionnaire of physical activity in children. Brief Physical Activity Assessment Tool (BPAAT) for adults (Parents) , apgar-family questionnaire. sociocultural level., educational level, Gender. Age. BMI parents, family antecedent. Analysis: Primary effectiveness. Initial comparability of groups according to the outcome and confusion variables. Mean differences in z score of BMI with 95% confidence intervals, between groups and generation of a multivariate and multilevel model. Analysis by intention to treat.

NCT ID: NCT04156971 Completed - Childhood Obesity Clinical Trials

Effects of Omega-3 Supplementation on Nutritional Status and Physical Activity of Obese Children

Start date: June 1, 2013
Phase: N/A
Study type: Interventional

Omega-3 Long-Chain Polyunsaturated Fatty Acids has potential as a supplement that can accelerate the effects of a weight management program in children. This study assessed the effects of fish oil supplementation on biochemical profile, body composition, diet and physical activity of obese children. A total of 37 obese children (7-11 years) were randomized to intervention (n=19) or control (n=18) group. Data were collected at baseline, at follow-up (every four weeks) and at 24 of the interventions. The intervention group (IG) received stage-based lifestyle modification intervention and fish oil supplement, while the control group (CG) received stage-based lifestyle modification intervention only. Changes in biochemical profile, body composition, diet and physical activity were examined in both intervention and control groups.

NCT ID: NCT04151823 Recruiting - Childhood Obesity Clinical Trials

Effect of POSTbiotics Supplementation on Microbiome in OBese Children: the POST-OB Study

POST-OB
Start date: January 7, 2019
Phase: Phase 4
Study type: Interventional

This study evaluates the possible effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, on gut microbiota composition and metabolite production. It also wants to determine whether postbiotics supplementation, combined with interventions to improve diet and lifestyle, reduces adverse metabolic consequences together with their co‐morbidities. All participants will follow a behaviour (promotion of physical activity) and dietary treatment according to Italian dietary guidelines for childhood obesity. Postbiotics and vitamin D3 will be given orally for four months; patients will be evaluated four months after supplementation and diet-lifestyle intervention and four months after the end of supplementation and after the alone diet-lifestyle intervention with blood testing and echosonography of the liver.

NCT ID: NCT04151758 Recruiting - Childhood Obesity Clinical Trials

Effect of Docosahexaenoic Acid Supplementation on Microbiome in Obese ChiLdrEn.

DAMOCLE
Start date: January 7, 2019
Phase: Phase 4
Study type: Interventional

Evaluation of the possible effect of DHA supplementation, combined with interventions aimed at improving diet and lifestyle, on gut microbiota composition and metabolite production.

NCT ID: NCT04126291 Completed - Childhood Obesity Clinical Trials

Type 2 Diabetes Prevention Toolkit for Health-Care Professionals

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Tools are limited to help health care professionals talk about weight-related issues with their pediatric patients. The investigators have developed 6 whiteboard videos for health care professionals based on the 5As of Pediatric Obesity Management to address weight-related issues with pediatric patients and their families. This study aims to evaluate the videos using pre and post questionnaires. With the questionnaires, the investigators want to evaluate the content, quality (acceptability, engagement) and impact of patient-oriented educational videos on HCPs' self-efficacy/confidence and knowledge in regards to addressing weight-related issues with pediatric patients and their families using the 5A framework.

NCT ID: NCT04112251 Not yet recruiting - Childhood Obesity Clinical Trials

Effects of COcoa Supplement in OBese Adolescent Subjects

COOBA
Start date: November 15, 2019
Phase: N/A
Study type: Interventional

Childhood obesity is a serious public health problem internationally. In addition to being associated with the early onset of chronic degenerative diseases such as diabetes, dyslipidemias, coronary artery diseases, among others. Changes in lifestyle habits are the main axis in the treatment of this disease; however, low adherence to these changes are reflected in the increase in their incidence and prevalence. There is diverse evidence that the use of flavonoids from cocoa such as (-) - epicatechin are able to prevent cardiovascular risks, decrease insulin resistance, mean arterial pressure, control the lipid profile; mediate oxidative stress, improve mitochondrial function and regulate the inflammatory process in patients with heart failure and diabetes mellitus. Therefore, our working hypothesis is the administration of the oral supplement of flavonoids from cocoa for 12 weeks will be able to reduce the percentage of body fat, improve the metabolic profile and regulate inflammatory and oxidative processes in obese patients 10-16 years, compared to those patients who only take a usual therapy consisting of recommendations of healthy diet and physical activity. For this, a randomized, double-blind, placebo-controlled clinical trial will be carried out, which will be carried out at the Federico Gómez Children's Hospital of Mexico, during the period from October 2019 to October 2020; with obese patients from 10 to 16 years distributed homogeneously at random in two groups: the control group (Placebo) and the intervention group (Flavonoids from cocoa) both groups affected for 12 weeks. The variables studied will be: percentage of muscle mass, percentage of fat, body mass index (BMI), waist circumference (CC), fasting glucose, fasting insulin, lipid profile (Total cholesterol, Triglycerides, HDL-c, LDL -c, Ratio TG / HDL-c, High Sensitivity C-Reactive Protein (HS-CRP), Interleukins (IL-6, IL-10), Tumor Growth Factor beta (TGF-β) and Tumoral Necrosis Factor alpha (TNF-α), carbonylated proteins, Malondialdehyde (MDA), indirect calorimetry by respiratory coefficient and treatment adherence.